ORCHESTRA德尔菲共识:实体器官移植受者SARS-CoV-2感染的诊断与治疗管理
该共识由ORCHESTRA研究框架下的专家组通过两轮德尔菲法制定,针对实体器官移植受者SARS-CoV-2感染的风险分层、诊断资源使用、治疗及移植相关管理形成10条共识声明,旨在为缺乏高质量证据的高危人群提供标准化诊疗框架。
要点
- 共识覆盖风险分层、诊断资源优化、抗病毒治疗与药物相互作用、免疫抑制剂调整及供受体管理五大领域。
- 21名专家来自意大利、西班牙、瑞士、巴西、美国、英国,经两轮德尔菲问卷最终形成10条声明。
- 首轮28项中18项达成共识,第二轮13项中9项达成共识,最终产出10条共识声明。
核心结论
- 该共识声明为实体器官移植受者SARS-CoV-2感染的标准化诊疗和改善结局提供了框架,该领域目前缺乏针对这一高危人群的高质量证据。
研究设计与样本
- 本研究为H2020资助的ORCHESTRA研究工作包4(脆弱人群队列)内开展的德尔菲共识研究。
主要发现
- 专家组由21名专家组成,其中女性13名、男性8名,来自意大利(n=11)、西班牙(n=5)、瑞士(n=2)、巴西(n=1)、美国(n=1)和英国(n=1)。
- 首轮28项问卷中18项达成共识,第二轮13项中9项达成共识,最终形成10条共识声明。
关键数值与推荐
- 共识声明涉及五大关键领域:实体器官移植作为重症演变风险因素的作用、诊断资源的最优使用(包括成本效益比和主动筛查适宜性)、人群特异性治疗管理(包括抗病毒使用、药物相互作用和治疗疗程)、免疫抑制剂撤除的潜在需求以及移植时近期和/或持续SARS-CoV-2感染的供受体管理。
临床怎么用
- 共识声明可为临床医生日常实践中管理实体器官移植受者SARS-CoV-2感染提供参考框架。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to address existing knowledge gaps regarding risk stratification, best use of diagnostic resources, optimal treatment, and general management of SARS-CoV-2 infection in solid organ transplant (SOT) recipients. As high-quality evidence specific to this fragile population is lacking, our final aim was to provide an expert consensus evidence-informed guidance that can aid clinicians in their daily practice. METHODS: This study was conducted within the Working Package 4 (fragile population cohorts) of the H2020-funded ORCHESTRA study (https://orchestra-cohort.eu). Eight infectious disease and one clinical pharmacology specialists conducted a comprehensive scoping literature review which covered five key areas: the role of SOT as a risk factor for evolution to severe disease; the optimal use of diagnostic resources, considering cost-benefit ratios and appropriateness of active screening; population-specific therapeutic management, including antiviral use and drug-drug interactions and appropriate duration of treatment; the potential need for withdrawal of immunosuppressive agents and management of potential donors and recipients with recent and/or ongoing SARS-CoV-2 infection at the time of transplantation. On the basis of this review, a 28-item questionnaire was developed and administered to a panel of experts through two rounds, following the Delphi methodology. RESULTS: The panel consisted of 21 experts, 13 females and 8 males, from Italy (n = 11), Spain (n = 5), Switzerland (n = 2), Brazil (n = 1), United States (n = 1), and United Kingdom (n = 1). Consensus was achieved for 18 out of 28 items after the first round and for 9 out of 13 items after the second round, according to agreement/disagreement levels obtained for each question and round, ten statements were finally produced. DISCUSSION: The consensus statements derived from this study offer a framework for standardizing care and improving outcomes in SOT recipients affected by SARS-CoV-2 infection in a field where high-quality evidence specific to this high-risk population is currently lacking.
引用
- Tazza B, Caroccia N, Toschi A, et al. ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in solid organ transplant recipients. Clin Microbiol Infect. 2025. PMID: 39954948. doi:10.1016/j.cmi.2025.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。